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Subcutaneous Sweet syndrome associated with
disseminated nontuberculous mycobacterial
infection leading to the diagnosis of
adult-onset immunodeficiency
To the Editor: A 51-year-old woman without notable
medical history presented with multiple 1.5- to 2-cm
tender, erythematous, and swollen nodules over the
legs, ankles, and soles (Fig 1) for 2 weeks. Fever upFig 1. Subcutaneous Sweet syndrome. A and B
nodules over bilateral legs and soles. C andD, Hist
panniculitis. (C and D, Hematoxylin-eosin stain; o
Open access under CC BY-NC-ND license.to 398C with chills was also noted. The remainder of
the physical examination revealed unremarkable
findings. Laboratory tests showed leukocytosis with
neutrophilia (white blood cell count 18,280/uL with
segments:75.1%), increased C-reactive protein (14
mg/dL), and elevated erythrocyte sedimentation rate
(60 mm/h). Histopathological examination of the
skin lesion showed neutrophilic lobular panniculitis
without vasculitis or any micro-organisms seen in
special stains (Fig 1). Blood chemistry, urinalysis,
antistreptolysin O antibody, hepatitis B virus
surface antigen, antihepatitis C virus antibody, anti-
nuclear antibody, cryoglobulins, antineutrophilic
cytoplasmic antibodies, and blood along with
tissue cultures produced negative or normal results.
Chest x-ray and chest computed tomography
showed mediastinal and right hilar lymphadenopa-
thy. Sputum cytology and culture were negative for
malignant cells or infection. The patient declined
computed tomographyeguided lymph node biopsy
for investigation of inflammatory, infectious, or
neoplastic diseases. The skin lesions gradually
improved after cefazolin and diclofenac use.
Because of uncertain origin of the lymphadenopathy
and possible occult infection, corticosteroid was not
further administered.
However, multiple tender erythematous nodules
over bilateral forearms occurred 1 month later and, Multiple deep painful and erythematous
opathological finding as neutrophilic lobular
riginal magnifications: C, 340; D, 3400.)
Fig 2. Disseminated nontuberculous mycobacterial infec-
tion. A, Bilateral neck swelling with tenderness 2 months
later. B, Clustered and enlarged lymph nodes over cervical
area. C, Biopsied lymph node specimen with the presence
of few acid fast-positive bacilli.
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as the previous skin biopsy specimen. Tissue culture
was still negative for bacteria, fungi, and acid-fast
bacilli. There was no detection of tuberculous or
nontuberculous mycobacterial (NTM) in the skin
tissue by polymerase chain reaction amplification. In
addition, progressively enlarged and tender lymph
nodes over bilateral neck (Fig 2) and intermittent
periods of fever were noticed. Follow-up blood
tests showed persistent leukocytosis, anemia, and
elevated C-reactive protein and erythrocyte sedi-
mentation rate levels with unremarkable findings in
autoimmune profiles, tumor markers, and viral
serology. Bone-marrow biopsy specimen revealed
reactive hyperplasia. Computed tomography scan
showed disseminated cervical, bilateral hilar, andintraabdominal lymphadenopathy (Fig 2). Histologic
examination of one of the cervical nodes showed
the presence of few acid fastepositive bacilli. The
culture of the biopsied lymph node yielded
Mycobacterium abscessus. Sputum culture also
showed the same species. The aforementioned
findings were consistent with the diagnosis of
subcutaneous Sweet syndrome associated with
disseminated NTM infection. Further immunologic
surveys including HIV, absolute T-lymphocyte
counts, and autoimmune indicators revealed normal
findings. However, high-titer antieinterferon-
autoantibodies were detected and pointed to the
diagnosis of adult-onset immunodeficiency. The
patient received amikacin and imipenem for 2
months and continued on prolonged doxycycline
and clarithromycin use.
Classic Sweet syndrome has been well docu-
mented as a reaction to NTM infections.1 However,
subcutaneous Sweet syndrome is mostly associated
with myeloid disorders,2 and some isolated cases
with multiple myeloma, breast carcinoma, and
Salmonella enteritidis infection.3 We here describe
a patient with subcutaneous Sweet syndrome
associated with disseminated NTM.
Adult-onset immunodeficiency related with
antieinterferon- autoantibodies has been recently
documented predominantly in East Asians.4,5
Reactive skin diseases with disseminated NTM
infection presented as common manifestations.4,5
However, detailed diagnostic process and histopath-
ological findings were not thoroughly demonstrated,
especially with reactive skin lesions as the first
clinical manifestation.
We herein report a patient with disseminated
NTM infection manifested as subcutaneous Sweet
syndrome first and further leading to the
diagnosis of adult-onset immunodeficiency related
to high-titer antieinterferon- autoantibodies.
Clinicians should be aware that cutaneous
symptoms may be the initial manifestations of
an undetected infection and an undiagnosed
immunodeficiency syndrome.
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Fig 1. Collodion baby. Tight, shiny film or dried collodion
reminiscent of the skin of a sausage covers the entire
surface of this 2-day-old neonate whose mother was
treated with infliximab throughout her pregnancy.
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Collodion-like membrane in a newborn
exposed to infliximab
To the Editor: A 2-day-old black female newborn,
born via cesarean section after premature rupture of
membranes (34 weeks’ gestation), had a collodion
membrane. Stellate cracking was present over the
entire cutaneous surface (Fig 1). There were no nail
abnormalities, bullae, ectropion, or eclabium. The
mother was treated for severe psoriasis and psoriatic
arthritis with a 7.5-mg/kg infusion of infliximab
every 6 weeks throughout pregnancy, and for 6
months before conception. She took no other
medications during her pregnancy. Newborn
genetic screening, complete blood cell count, and
comprehensive metabolic panel test results were
within normal limits, and there was no history
of consanguinity. There was no family history
of bullous congenital ichthyosiform erythroderma
or lamellar ichthyosis. Treatment was initiated with
a petrolatum-based ointment (Aquaphor, Beiersdorf
Inc, Wilton, CT). The collodion membrane shed
completely and the skin normalized over 2 months.
The skin was normal-appearing at age 1 year.
The mean age of onset of psoriasis is during
the 20s and 30s, the peak childbearing years.
Although the hormonal changes of pregnancy can
improve psoriasis, approximately 20% worsen.1
Psoriatic arthritis, severe in 5% of patients, can be
quite destructive. Inflammatory cytokines such as
interleukin 17 and tumor necrosis factor (TNF)-alfa
inhibit the T-helper cell type 17 axis inducinginflammation and defects in keratinocyte differen-
tiation producing psoriatic plaques.2 TNF-alfa
inhibitors, such as infliximab, are remarkably
effective in controlling both psoriasis and psoriatic
arthritis.2
Infliximab, a complete chimeric monoclonal IgG1
antibody, is a potent antieTNF-alfa biologic agent
delivered by infusion. It is designated Food and
Drugs Administration (FDA) category B because
animal reproduction studies did not demonstrate a
risk but well-controlled studies in human pregnancy
have not been done.3 The Fc receptors on
trophoblasts help to actively transport all biological
agents with an IgG Fc region. Therefore, the
transplacental passage of monoclonal antibodies
such as infliximab and adalimumab is greater than
in etanercept.
An FDA database review of 41 children born
to mothers taking a TNF antagonist demonstrated
congenital anomalies in 24 children (59%).3 Of the
anomalies reported, 56% were part of the vertebral
defects, anal atresia, cardiac defects, tracheoesopha-
geal fistula, renal anomalies, and limb abnormalities
(VACTERL) spectrum, but only 1 child was diagnosed
with VACTERL. A retrospective analysis of pregnancy
outcomes of 32 women exposed to antieTNF-alfa
inhibitors demonstrated no increased risk to the
patients and fetuses, although the paucity of data
precluded a recommendation for regular use in
pregnancy.4
Although collodion membrane associated with
antieTNF biologic agents has not been reported to
our knowledge, there are several examples of
paradoxical inducement of keratinization abnorma-
lities. New-onset psoriasis has occurred in a series of
patients with rheumatologic conditions treated
with TNF-alfa inhibitors.5,6 The pathogenesis of
these paradoxical reactions may be the result of
overexpression of interferon because of the
cross-regulation between TNF-alfa and interferon.
